Overview

SYTE.bio is an early-stage synthetic biology company focused on the discovery, development and future commercialization of precision therapeutics using its proprietary Linear DNA and Circular RNA technology platforms. SYTE.bio aims to deliver novel and effective therapeutics and vaccines enabling precise corrective and preventive treatments for patients worldwide.